AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Nurix Therapeutics Executives Sell Shares at $12.01 per Share.
ByAinvest
Wednesday, Jul 30, 2025 6:54 pm ET1min read
Nurix Therapeutics, Inc. [NRIX] has announced that Hansen Gwenn, Chief Scientific Officer, has sold 4308 shares at a price of $12.01 per share on July 30, 2025. Furthermore, Christine Ring, Chief Legal Officer, and Hans van Houte, Chief Financial Officer, have also sold shares at the same price on the same day, with Ring disposing of 3841 shares and van Houte selling 4304 shares.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet